These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 7267304)

  • 1. [A study of the diffusion of cefamandole into bronchial secretions (author's transl)].
    Bergogne-Berezin E; Berthelot G; Even P
    Nouv Presse Med; 1981 Jun; 10(25):2089-91. PubMed ID: 7267304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Experimental and clinical study of the biliary excretion of cefamandole (author's transl)].
    Brogard JM; Pinget M; Arnaud JP; Dorner M; Adloff M; Lavillaureix J
    Pathol Biol (Paris); 1981 Jan; 29(1):25-30. PubMed ID: 7010273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Penetration of cefsulodin into bronchial secretions.
    Bergogne-Berezin E; Berthelot G; Safran D; Even P; Kafe H
    Chemotherapy; 1984; 30(4):205-10. PubMed ID: 6744972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diffusion of cefamandole into the prostatic tissue (author's transl)].
    Adam D; Hofstetter AG; Eisenberger F
    Med Klin; 1979 Feb; 74(7):235-8. PubMed ID: 84331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [penetration of fosfomycin into bronchial secretions].
    Berthelot G; Bergogne-Berezin E; Kafe H; Daumal M; Gillon JC
    Pathol Biol (Paris); 1983 Jun; 31(6):519-21. PubMed ID: 6348660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Studies on the diffusion rate of cefamandole in various human tissue (author's transl)].
    Plaue R; Müller O; Fabricius K; Bethke RO
    Arzneimittelforschung; 1978; 28(12):2343-9. PubMed ID: 582953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacokinetics of mezlocillin in bronchial secretions (author's transl)].
    Bergogne-Berezin E; Pierre J; Even P; Reynaud P
    Nouv Presse Med; 1982 Feb; 11(5 Pt 2):361-4. PubMed ID: 6460976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Fundamental and clinical studies on cefamandole in the field of obstetrics and gynecology (author's transl)].
    Hirabayashi K; Okada E
    Jpn J Antibiot; 1980 Apr; 33(4):416-26. PubMed ID: 6997530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Penetration of netilmicin into respiratory secretions].
    Bergogne-Berezin E; Berthelot G; Even P; Safran D
    Presse Med; 1983 Feb; 12(5):287-92. PubMed ID: 6220386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study of the diffusion of cefmenoxime into the bronchial secretions.
    Serieys C; Bergogne-Berezin E; Kafe H; Bryskier A
    Chemotherapy; 1986; 32(1):1-6. PubMed ID: 3456295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Penetration of mezlocillin into bronchial secretions (author's transl)].
    Morel C; Benard Y; Vergnaud M; Langeard M
    Nouv Presse Med; 1982 Feb; 11(5 Pt 2):365-7. PubMed ID: 6460977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diffusion of cefotaxime in the interstitial fluid of rabbits. Comparison with cefazolin, cefoxitin and cefamandole (author's transl)].
    Boussougant Y; Contrepois A; Doquir C; Carbon C
    Nouv Presse Med; 1981 Feb; 10(8):591-3. PubMed ID: 6259599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Penetration of cefotaxime into bronchial secretions].
    Bergogne-Berezin E; Morel C; Pierre J; Monrocq N; Dournovo P; Benard Y
    Pathol Biol (Paris); 1982 Jun; 30(6 Pt 2):501-5. PubMed ID: 6289226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Penetration of cefotaxime into bronchial secretions.
    Bergogne-Berezin E; Morel C; Pierre J; Monrocq N; Dournovo P; Benard Y
    Rev Infect Dis; 1982; 4 Suppl():S392-5. PubMed ID: 6294788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Concentration of cefamandole in human renal parenchyma (author's transl)].
    Kroening U; Brückner O; Nagel R
    Arzneimittelforschung; 1981; 31(11):1976-9. PubMed ID: 7198478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diffusion of piperacillin into bronchial secretions].
    Bergogne-Bérézin E; Berthelot G; Kafe H
    Pathol Biol (Paris); 1986 Jun; 34(5 Pt 2):653-6. PubMed ID: 3534762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of ceftazidime and cefamandole pharmacokinetics and blister fluid concentrations.
    Armstrong GC; Wise R; Brown RM; Hancox J
    Antimicrob Agents Chemother; 1981 Sep; 20(3):356-8. PubMed ID: 7030200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the pharmacokinetics of cefamandole and other cephalosporin compounds.
    Neu HC
    J Infect Dis; 1978 May; 137 Suppl():S80-S87. PubMed ID: 650006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Laboratory and clinical studies on cefamandole in pediatric field (author's transl)].
    Hori M; Kohno S; Hashimoto F; Matsunaga T; Kurosu Y; Toyonaga Y; Takahashi T
    Jpn J Antibiot; 1979 Nov; 32(11):1091-100. PubMed ID: 513291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Excretion of cefamandole, cefazolin, and cephalothin into T-tube bile.
    Ratzan KR; Baker HB; Lauredo I
    Antimicrob Agents Chemother; 1978 Jun; 13(6):985-7. PubMed ID: 677864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.